threatening emergent situations where obtaining
prospective informed consent has been waived, is provided by 21 CFR 50.24. The research
plan must be approved in advance by FDA and the IRB, and publicly disclosed to the
community in which the research will be conducted. Such studies are usually not eligible
for the emergency approvals described above. The information sheet &quot;Exception from
Informed Consent for Studies Conducted in Emergency Settings: Regulatory Language and
Excerpts from Preamble,&